Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase for Dysfunctional Central Venous Catheters
NCT00395876Phase 3Completed
- Sponsor
- Genentech
- Start
- Nov 2006
- Primary completion
- Jun 2008
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of tenecteplase in central venous catheter occlusion, sponsored by Genentech. Started Nov 2006; status: completed.
02
Drugs
tenecteplase
03
Conditions
central venous catheter occlusion
Beyond the preview
Go deeper on NCT00395876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395876.